Studies related to the absolute configuration of cyclocinamide A: Total synthesis of 4(R),11(R)-cyclocinamide A

Tetrahedron Letters

Volumn 39, Issue 49, 1998, Pages 8925-8928

  Grieco, Paul A ^a   Reilly, Michael ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOCINAMIDE A; HEXAPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; REACTION ANALYSIS;

EID: 0032481015     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)02016-4     Document Type: Article

References (18)

1. 1. Clark, W. D.; Corbett, T.; Valeriote, F.; Crews, P. J. Am. Chem. Soc. 1997, 119, 9285.
2. 12 This in vitro assay defines solid tumor selective compounds by quantitating differential cytotoxic activity between murine and human solid tumor cells and either murine leukemia or normal cells. Purified 1 was tested against a murine leukemia (L1210) and a murine solid tumor (colon 38). Cyclocinamide A exhibited outstanding solid tumor selecivity against colon 38.
3. 3. Irie, K.; Ishida, A.; Nakamura, T.; Oh-ishi, T. Chem. Pharm. Bull. 1984, 32, 2126.
4. 4. Bednarek, M. A.; Bodansky, M. Int. J. Pept. Protein Res. 1983, 21, 196. Kessler, H.; Siegmeier, R. Tetrahedron Lett. 1983, 24, 281.
5. 4. Bednarek, M. A.; Bodansky, M. Int. J. Pept. Protein Res. 1983, 21, 196. Kessler, H.; Siegmeier, R. Tetrahedron Lett. 1983, 24, 281.
6. 5. Milewska, M. J.; Polonski, T. Synthesis 1988, 475.
7. 6. Available from Sigma Chemical Company.
8. 7. Cf. Zhang, L.; Chung, J. C.; Costello, T. D.; Valvis, I.; Ma, P.; Kauffman, S.; Ward, R. J. Org. Chem. 1997, 62, 2466.
9. 8. Paquet, A. Can. J. Chem. 1982, 60, 976. For a review of the use of Fmoc protection in peptide synthesis, see: Atherton, E.; Sheppard, R. C., "The Fluorenylmethoxycarbonyl Amino Protecting Group," in The Peptides., Udenfriend, S.; Meienhofer, J., Eds., Academic Press, Orlando, FL, 1987, Vol. 9, pp. 1-38.
10. 8. Paquet, A. Can. J. Chem. 1982, 60, 976. For a review of the use of Fmoc protection in peptide synthesis, see: Atherton, E.; Sheppard, R. C., "The Fluorenylmethoxycarbonyl Amino Protecting Group," in The Peptides., Udenfriend, S.; Meienhofer, J., Eds., Academic Press, Orlando, FL, 1987, Vol. 9, pp. 1-38.
11. 9. Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Tetrahedron Lett. 1975, 1219. Also see: Jou, G.; González, I.; Albericio, F.; Lloyd-Williams, P.; Giralt, E. J. Org. Chem. 1997, 62, 354.
12. 9. Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Tetrahedron Lett. 1975, 1219. Also see: Jou, G.; González, I.; Albericio, F.; Lloyd-Williams, P.; Giralt, E. J. Org. Chem. 1997, 62, 354.
13. 10. Chen, S.; Xu, J. Tetrahedron Lett. 1991, 32, 6711. Dudash, J.; Jiang, J.; Mayer, S. C.; Joullié, M. M. Syn. Commun. 1993, 23, 349.
14. 10. Chen, S.; Xu, J. Tetrahedron Lett. 1991, 32, 6711. Dudash, J.; Jiang, J.; Mayer, S. C.; Joullié, M. M. Syn. Commun. 1993, 23, 349.
15. 11. Nishiwaki, E.; Tanaka, S.; Lee, H.; Shibuya, M. Heterocycles 1988, 27, 1945. Matsumoto, T.; Utsumi, Y.; Sakai, Y.; Toyooka, K.; Shibuya, M. Heterocycles 1992, 34, 1697.
16. 11. Nishiwaki, E.; Tanaka, S.; Lee, H.; Shibuya, M. Heterocycles 1988, 27, 1945. Matsumoto, T.; Utsumi, Y.; Sakai, Y.; Toyooka, K.; Shibuya, M. Heterocycles 1992, 34, 1697.
17. 12. Valeriote, F.; Corbett, T.; LoRusso, P.; Moore, R. E.; Scheuer, P.J.; Patterson, G.; Paul, V.; Grindey, G.; Bonjouklian, R.; Pearce, H.; Suffness, M. I. J. Pharmacognosy 1995, 33, Suppl. 59. Valeriote, F.; Corbett, T.; Edelstein, M.; Baker, L. Cancer Invest. 1996, 14, 124.
18. 12. Valeriote, F.; Corbett, T.; LoRusso, P.; Moore, R. E.; Scheuer, P.J.; Patterson, G.; Paul, V.; Grindey, G.; Bonjouklian, R.; Pearce, H.; Suffness, M. I. J. Pharmacognosy 1995, 33, Suppl. 59. Valeriote, F.; Corbett, T.; Edelstein, M.; Baker, L. Cancer Invest. 1996, 14, 124.